1. Home
  2. ATNM vs AIRE Comparison

ATNM vs AIRE Comparison

Compare ATNM & AIRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATNM
  • AIRE
  • Stock Information
  • Founded
  • ATNM 2000
  • AIRE 2021
  • Country
  • ATNM United States
  • AIRE United States
  • Employees
  • ATNM N/A
  • AIRE N/A
  • Industry
  • ATNM Biotechnology: Pharmaceutical Preparations
  • AIRE
  • Sector
  • ATNM Health Care
  • AIRE
  • Exchange
  • ATNM Nasdaq
  • AIRE Nasdaq
  • Market Cap
  • ATNM 56.5M
  • AIRE 52.4M
  • IPO Year
  • ATNM N/A
  • AIRE N/A
  • Fundamental
  • Price
  • ATNM $1.73
  • AIRE $1.18
  • Analyst Decision
  • ATNM Strong Buy
  • AIRE
  • Analyst Count
  • ATNM 5
  • AIRE 0
  • Target Price
  • ATNM $14.20
  • AIRE N/A
  • AVG Volume (30 Days)
  • ATNM 285.8K
  • AIRE 58.3K
  • Earning Date
  • ATNM 10-31-2024
  • AIRE 12-13-2024
  • Dividend Yield
  • ATNM N/A
  • AIRE N/A
  • EPS Growth
  • ATNM N/A
  • AIRE N/A
  • EPS
  • ATNM N/A
  • AIRE N/A
  • Revenue
  • ATNM $81,000.00
  • AIRE $99,036.00
  • Revenue This Year
  • ATNM $186.10
  • AIRE N/A
  • Revenue Next Year
  • ATNM $19,248.94
  • AIRE N/A
  • P/E Ratio
  • ATNM N/A
  • AIRE N/A
  • Revenue Growth
  • ATNM 80.00
  • AIRE N/A
  • 52 Week Low
  • ATNM $1.33
  • AIRE $0.53
  • 52 Week High
  • ATNM $10.24
  • AIRE $575.41
  • Technical
  • Relative Strength Index (RSI)
  • ATNM 41.48
  • AIRE 40.93
  • Support Level
  • ATNM $1.48
  • AIRE $1.15
  • Resistance Level
  • ATNM $1.80
  • AIRE $1.23
  • Average True Range (ATR)
  • ATNM 0.12
  • AIRE 0.06
  • MACD
  • ATNM 0.04
  • AIRE -0.00
  • Stochastic Oscillator
  • ATNM 54.44
  • AIRE 23.81

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

About AIRE reAlpha Tech Corp.

ReAlpha Tech Corp is an early-stage company that develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It offers retail investors the opportunity to participate in short-term rental properties it will acquire by offering interest in each property portfolio. Its revenues consist of short-term rental revenues from the rental of its properties via Airbnb and such digital hospitality platforms. The company has two segments (i) platform services and (ii) rental business. The company generates the majority of its revenue from the Platform services segment.

Share on Social Networks: